Article Versions Notes

Derman B, Tan C, Steinfield I, Wilson FR, Lin D, Wu B, Fernandez M, Fowler J, Paner-Straseviciute A, Kim N, et al. Real-World Evidence Evaluating Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma: A Systematic Literature Review. Cancers. 2025; 17(7):1235. https://doi.org/10.3390/cancers17071235

Derman, Benjamin, Carlyn Tan, Ian Steinfield, Florence R. Wilson, Dee Lin, Bingcao Wu, Mariana Fernandez, Jessica Fowler, Agne Paner-Straseviciute, Nina Kim, and et al. 2025. "Real-World Evidence Evaluating Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma: A Systematic Literature Review" Cancers 17, no. 7: 1235. https://doi.org/10.3390/cancers17071235

Derman, B., Tan, C., Steinfield, I., Wilson, F. R., Lin, D., Wu, B., Fernandez, M., Fowler, J., Paner-Straseviciute, A., Kim, N., Doyle, M., Marshall, A., Cheadle, J., Keeping, S., & Liu, J. J. (2025). Real-World Evidence Evaluating Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma: A Systematic Literature Review. Cancers, 17(7), 1235. https://doi.org/10.3390/cancers17071235